Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
RPG Life Sciences Limited
RPGLIFERPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology, cardiovascular, pediatrics, neurology, anti-dengue, and dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust. Address: RPG House, Mumbai, India, 400030
Analytics
Precio Objetivo de WallStreet
40 359.09 INRRelación P/E
50.5011Rentabilidad por dividendo
0.75 %Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave RPGLIFE
Análisis de dividendos RPGLIFE
Aumento del dividendo durante 5 años
400 %Crecimiento continuo
4 añoRatio de pago medio en 5 años
30 %Tendencia del payout RPGLIFE
Valoración de la acción RPGLIFE
Finanzas RPGLIFE
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |